Tauriga Sciences Inc.'s Advertising Campaign in Times Square Goes Live
October 19 2021 - 1:56PM
InvestorsHub NewsWire
This Campaign is Focused on the
Company’s Flagship Brand:
Tauri-Gum™
NEW YORK, NY -- October 19, 2021 -- InvestorsHub
NewsWire -- Tauriga Sciences, Inc. (OTCQB: TAUG)
(“Tauriga” or the “Company”), a New York based diversified Life
Sciences Company, today announced that its Advertising Campaign in
Times Square (New York City), has Gone Live! This Advertising
Campaign is expected to run through January 5, 2022. The
Company expects for its flagship brand, Tauri-Gum™, to benefit from
the substantial exposure and constant
eyeballs.
Additionally, the Company’s
Advertisement will be running during New Year’s Eve 2021 (December
31, 2021). Times Square is always a popular location during
New Year’s
Eve.
The Campaign itself consists of a
large digital billboard platform, located within the following
Venue: The 1500 Broadway Spectacular, strategically positioned in
the heart of the Times Square Plaza, “The Gateway to New
York”.
The actual digital billboard,
itself, is 56 feet wide by 29 feet tall, for a total of 1,624
square feet of viewing
space.
Over the course of this 83-day
advertising campaign (the “campaign”), the airtime package
guarantees a minimum of five 15 second Tauri-Gum™ advertisements
per hour / airing 20 hours per day. Over the course of
the campaign, there will be a minimum of 8,300 of the
above-referenced 15 second Tauri-Gum™
advertisements.
This Advertising Campaign is Titled:
“83 Days in the Big
Apple”
ABOUT TAURIGA SCIENCES
INC.
Tauriga Sciences, Inc. (TAUG)
is a revenue generating, diversified life sciences company, engaged
in several major business activities and
initiatives. The company manufactures and distributes
several proprietary retail products and product lines, mainly
focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles
market segment. The main product line, branded as
Tauri-Gum™, consists of a proprietary supplement chewing gum that
is Kosher certified, Halal certified, and Vegan Formulated (CBD
Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG
Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant), (DELTA 8
THC Infused Tauri-Gum™ Flavor: Evergreen Mint), (Vitamin C + Zinc
Infused Tauri-Gum™ Flavor: Pear Bellini), (Caffeine Infused
Tauri-Gum™ Flavor: Cherry Lime Rickey), & (Vitamin D3 Infused
Tauri-Gum™ Flavor: Golden Raspberry). The Company’s
commercialization strategy consists of a broad array of retail
customers, distributors, and a fast-growing E-Commerce business
segment (E-Commerce website: www.taurigum.com). Please visit
our corporate website, for additional information, as well as
inquiries, at http://www.tauriga.com
Complementary to the Company’s
retail business, is its ongoing Pharmaceutical Development
initiative. This relates to the development of a proposed
Pharmaceutical grade version of Tauri-Gum™, for nausea regulation
(specifically designed for the following indication: Patients
Subjected to Ongoing Chemotherapy Treatment). On March 22, 2021,
the Company announced that it had Converted its U.S. Provisional
Patent Application (filed on March 17, 2020) into a U.S.
Non-Provisional Patent Application. The Patent, filed
with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS
OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18,
2020 the Company disclosed that it had entered into a Master
Services Agreement with CSTI to lead the Company's clinical
development efforts.
The Company is headquartered in
Wappingers Falls, New York. In addition, the Company
operates two full time E-Commerce fulfillment centers: one located
in Montgomery, Texas and the other in Brooklyn, New
York.
DISCLAIMER -- Forward-Looking
Statements
This press release contains certain
“forward-looking statements” as defined by the Private Securities
Litigation Reform Act of 1995 which represent management’s beliefs
and assumptions concerning future events. These forward-looking
statements are often indicated by using words such as “may,”
“will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or
plans, and may include statements regarding corporate objectives as
well as the attainment of certain corporate goals and milestones.
Forward-looking statements are based on present circumstances and
on management’s present beliefs with respect to events that have
not occurred, that may not occur, or that may occur with different
consequences or timing than those now assumed or anticipated.
Actual results may differ materially from those expressed in
forward looking statements due to known and unknown risks and
uncertainties, such as are not guarantees of general economic and
business conditions, the ability to successfully develop and market
products, consumer and business consumption habits, the ability to
consummate successful acquisition and licensing transactions,
fluctuations in exchange rates, and other factors over which
Tauriga has little or no control. Many of these risks and
uncertainties are discussed in greater detail in the “Risk Factors”
section of Tauriga’s Form 10-K and other periodic filings made from
time to time with the Securities and Exchange Commission. Such
forward-looking statements are made only as of the date of this
release, and Tauriga assumes no obligation to update
forward-looking statements to reflect subsequent events or
circumstances. You should not place undue reliance on these
forward-looking
statements.
Contact:
Tauriga Sciences,
Inc.
4 Nancy Court, Suite
4
Wappingers Falls, NY
12590
Chief Executive
Officer
Mr. Seth M.
Shaw
Email: sshaw@tauriga.com
cell # (917) 796
9926
Company Instagram:
@taurigum
Personal
Instagram: @sethsms47
Twitter:
@SethMShaw
Corp.
Website: www.tauriga.com
E-Commerce
Website: www.taurigum.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Sep 2023 to Sep 2024